We are live on ! Find out more
TELA icon

TELA Bio

32 hedge funds and large institutions have $95M invested in TELA Bio in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

234% more capital inflows, than outflows

Capital inflows: $25.2M | Capital outflows: $7.55M

100% more funds holding in top 10

Funds holding in top 10: 2 → 4 (+2)

83% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 6

33% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 6

16.25% more ownership

Funds ownership: 76.71% → 92.96% (+16%)

7% more funds holding

Funds holding: 30 → 32 (+2)

Holders
32
Holders Change
+2
Holders Change %
+6.67%
% of All Funds
0.54%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.07%
New
8
Increased
11
Reduced
6
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

TELA Hedge Fund Activity: Q2 2022 in Review

32 of the 5,965 institutional investors tracked by Wall St. Rank reported a position in TELA Bio (TELA) for Q2 2022, worth a combined $95M — down 27% from $130M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new TELA positions and 6 closed out — a net gain of 2 holders — while 11 added to existing stakes and 6 trimmed.

The largest buyer was Opaleye Management, adding an estimated $9.7M. The largest seller was Silvercrest Asset Management, exiting entirely with an estimated $4.61M sold.

  • 32 institutional investors held TELA Bio (TELA) as of Q2 2022, up from 30 in Q1 2022.
  • Funds reported $95M of TELA Bio stock for Q2 2022, down 27% quarter-over-quarter.
  • 8 funds opened new TELA Bio positions in Q2 2022 and 6 closed out, a net change of +2 holders.
  • The largest TELA Bio buyer in Q2 2022 was Opaleye Management, an estimated $9.7M added.
  • The largest TELA Bio seller in Q2 2022 was Silvercrest Asset Management, an estimated $4.61M sold.

Based on aggregated 13F filings for Q2 2022.